| scholarly article | Q13442814 |
| P2093 | author name string | Murakami T | |
| Yoshimura K | |||
| Matsushita S | |||
| Takatsuki K | |||
| Matsumi S | |||
| Morikita T | |||
| P2860 | cites work | Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies | Q41621929 |
| The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? | Q41701302 | ||
| Selective killing of HIV-infected cells by anti-gp120 immunotoxins | Q41744773 | ||
| Two neutralizing domains in the V3 region in the envelope glycoprotein gp125 of HIV type 2. | Q44233059 | ||
| The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques | Q44357802 | ||
| Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1. | Q44809362 | ||
| HIV-2 in rhesus monkeys: serological, virological and clinical results | Q44811904 | ||
| Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant | Q45018234 | ||
| Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses | Q45831194 | ||
| The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule | Q69029864 | ||
| Experimental infection of cynomolgus monkeys (Macaca fascicularis) with HIV-2 | Q93515302 | ||
| The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus | Q28259668 | ||
| Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells | Q28288205 | ||
| T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV | Q28646817 | ||
| The genome organization of STLV-3 is similar to that of the AIDS virus except for a truncated transmembrane protein | Q30405844 | ||
| Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides | Q33560772 | ||
| Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120 | Q33571605 | ||
| Evolutionary origin of human and simian immunodeficiency viruses | Q33604826 | ||
| Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone | Q33848331 | ||
| Identification and characterization of fusion and processing domains of the human immunodeficiency virus type 2 envelope glycoprotein | Q33935988 | ||
| Isolation of a new human retrovirus from West African patients with AIDS. | Q34038984 | ||
| Genome organization and transactivation of the human immunodeficiency virus type 2. | Q34048704 | ||
| Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses | Q36470925 | ||
| Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein | Q36632605 | ||
| Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop | Q36651187 | ||
| Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys | Q36683893 | ||
| Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates | Q36698091 | ||
| In vivo genetic variability of the human immunodeficiency virus type 2 V3 region | Q36699146 | ||
| Persistent infection of rhesus macaques with a molecular clone of human immunodeficiency virus type 2: evidence of minimal genetic drift and low pathogenetic effects | Q36783146 | ||
| CD4 immunoadhesin, but not recombinant soluble CD4, blocks syncytium formation by human immunodeficiency virus type 2-infected lymphoid cells | Q36784444 | ||
| Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding | Q36795606 | ||
| Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS. | Q36829102 | ||
| The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1 | Q36839199 | ||
| Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope | Q36869394 | ||
| Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity | Q37546827 | ||
| Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop. | Q38307572 | ||
| Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region | Q40061779 | ||
| Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4 | Q40065815 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | monoclonal antibody | Q422248 |
| P304 | page(s) | 3333-3340 | |
| P577 | publication date | 1995-06-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120 | |
| P478 | volume | 69 |
| Q27667679 | Crystal Structure of the HIV-2 Neutralizing Fab Fragment 7C8 with High Specificity to the V3 Region of gp125 |
| Q33809419 | Evolutionary and structural features of the C2, V3 and C3 envelope regions underlying the differences in HIV-1 and HIV-2 biology and infection |
| Q40760950 | Fine characterization of a V3-region neutralizing epitope in human immunodeficiency virus type 2. |
| Q36651031 | HIV-2 and its role in conglutinated approach towards Acquired Immunodeficiency Syndrome (AIDS) Vaccine Development |
| Q34611466 | HIV-2 interaction with cell coreceptors: amino acids within the V1/V2 region of viral envelope are determinant for CCR8, CCR5 and CXCR4 usage |
| Q41823383 | HIV-2 neutralization by intact V3-specific Fab fragments |
| Q74497693 | Linear and cyclic peptides mimicking the disulfide loops in HIV-2 envelope glycoprotein induced antibodies with different specificity |
| Q39875204 | Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein |
| Q35896178 | Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus. |
| Q35873035 | Possible role of the V3 domain of gp120 in resistance to an amphotericin B derivative (MS8209) blocking human immunodeficiency virus entry |
| Q34290973 | Potent and broadly reactive HIV-2 neutralizing antibodies elicited by a vaccinia virus vector prime-C2V3C3 polypeptide boost immunization strategy |
| Q45724156 | Serum immunoglobulin A (IgA)-mediated immunity in human immunodeficiency virus type 2 (HIV-2) infection |
| Q45967960 | Solution conformation of an immunogenic peptide derived from the principal neutralizing determinant of the HIV-2 envelope glycoprotein gp125. |
| Q57003406 | Structure/antigenicity relationship of cyclic and linear peptides mimicking the V3 loop of HTV2 envelope glycoprotein |
Search more.